Explore the most recent editions of MPO Magazine, featuring expert commentary, industry trends, and breakthrough technologies.
Access the full digital version of MPO Magazine anytime, anywhere, with interactive content and enhanced features.
Join our community of medical device professionals. Subscribe to MPO Magazine for the latest news and updates delivered straight to your mailbox.
Explore the transformative impact of additive manufacturing on medical devices, including design flexibility and materials.
Learn about outsourcing options in the medical device sector, focusing on quality, compliance, and operational excellence.
Stay updated on the latest electronic components and technologies driving innovation in medical devices.
Discover precision machining and laser processing solutions that enhance the quality and performance of medical devices.
Explore the latest materials and their applications in medical devices, focusing on performance, biocompatibility, and regulatory compliance.
Learn about advanced molding techniques for producing high-quality, complex medical device components.
Stay informed on best practices for packaging and sterilization methods that ensure product safety and compliance.
Explore the latest trends in research and development, as well as design innovations that drive the medical device industry forward.
Discover the role of software and IT solutions in enhancing the design, functionality, and security of medical devices.
Learn about the essential testing methods and standards that ensure the safety and effectiveness of medical devices.
Stay updated on innovations in tubing and extrusion processes for medical applications, focusing on precision and reliability.
Stay ahead with real-time updates on critical news affecting the medical device industry.
Access unique content and insights not available in the print edition of the MPO Magazine.
Explore feature articles that delve into specific topics within the medical device industry, providing in-depth analysis and insights.
Gain perspective from industry experts through regular columns addressing key challenges and innovations in medical devices.
Read the editor’s thoughts on the current state of the medical device industry.
Discover the leading companies in the medical device sector, showcasing their innovations and contributions to the industry.
Explore detailed profiles of medical device contract manufacturing and service provider companies, highlighting their capabilities and offerings.
Learn about the capabilities of medical device contract manufacturing and service provider companies, showcasing their expertise and resources.
Watch informative videos featuring industry leaders discussing trends, technologies, and insights in medical devices.
Short, engaging videos providing quick insights and updates on key topics within the medical device industry.
Tune in to discussions with industry experts sharing their insights on trends, challenges, and innovations in the medical device sector.
Participate in informative webinars led by industry experts, covering various topics relevant to the medical device sector.
Stay informed on the latest press releases and announcements from leading companies in the medical device manufacturing industry.
Access comprehensive eBooks covering a range of topics on medical device manufacturing, design, and innovation.
Highlighting the innovators and entrepreneurs who are shaping the future of medical technology.
Explore sponsored articles and insights from leading companies in the medical device manufacturing sector.
Read in-depth whitepapers that explore key issues, trends, and research findings for the medical device industry.
Discover major industry events, trade shows, and conferences focused on medical devices and technology.
Get real-time updates and insights from major medical device shows and exhibitions happening around the world.
Join discussions and networking opportunities at the MPO Medtech Forum, focusing on the latest trends and challenges in the industry.
Attend the MPO Summit for insights and strategies from industry leaders shaping the future of medical devices.
Participate in the ODT Forum, focusing on orthopedic device trends and innovations.
Discover advertising opportunities with MPO to reach a targeted audience of medical device professionals.
Review our editorial guidelines for submissions and contributions to MPO.
Read about our commitment to protecting your privacy and personal information.
Familiarize yourself with the terms and conditions governing the use of MPOmag.com.
What are you searching for?
Despite the divorce, tensions between ex-Masimo CEO Joe Kiani and Politan still linger.
September 2, 2025
By: Michael Barbella
Managing Editor
It was a hard lesson to learn. But it could be the most valuable of Joe Kiani’s career.
Never one to eschew confrontation or give up easily, Kiani has spent his entire entrepreneurial career championing better patient care. His dedication to improving the pulse oximeter is unparalleled: Kiani spent more than three decades growing the garage startup concept into a global medtech powerhouse.
Over the years, Kiani has had to fend off intellectual property challenges from other companies and market access roadblocks from group purchasing organizations. As the owner of more than 500 patents or patent applications related to advanced signal processing, optical sensors, and wearable solutions, he’s been fiercely protective of the signal extraction technology he developed for his first company—Irvine, Calif.-based Masimo.
That technology (Masimo SET) distinguishes between noise caused by blood flow and interference from motion like walking, shivering, or other movements. Such proficiency eliminated the potential for false readings, transforming Masimo’s pulse oximeters into the gold standard in noninvasive blood oxygen level monitoring and pulse signal/fluid responsiveness in patients.
Not surprisingly, Masimo’s pulse oximetry solution has garnered lots of attention in recent decades—good and bad. The good: multiple U.S. Food and Drug Administration product clearances, a 200 million-patient-plus user base, a “Most Innovative Companies in North America” designation (Fast Company), and Newsweek top hospital customers.
The bad: a poorly-received billion-dollar acquisition (Sound United), a $5 billion market value loss (resulting from the 2022 deal), scrutiny from an activist hedge fund founder, and a very public patent infringement battle with Apple.
The two latter miscues helped set the stage for Kiani’s eventual ouster as Masimo’s leader. As Kiani’s firm and Apple traded legal barbs over supposed employee pilfering, smartwatch mimicking, and trade secret stealing, veteran investor Quentin Koffey—who founded activist hedge fund Politan Capital Management in 2021—grew increasingly concerned about Masimo’s governance capabilities, believing the company had given Kiani too much power. Within six months, Politan acquired nearly 9% of Masimo.
Such was the birth of Kiani’s hard-learned lesson.
“Never give up control to outsiders,” he told a marketer/podcaster earlier this year who asked him to relay the most painful lesson he’d learned in his tenure as Masimo’s founder/president/CEO. “It’s OK to give equity to friends, family, and people you know. But never to strangers.”
Alas, knowledge gained a little too late for Kiani. The bitter, two-year proxy battle he waged with Politan ended last fall with Kiani’s resignation from Masimo upon Politan assuming control of its six-member board.
Despite the divorce, tensions between Kiani and Politan still linger. Barely a month after the proxy battle victory, Masimo’s new management sued Kiani, claiming he colluded with RTW Investments LP on an “empty voting” scheme to manipulate the board election. Filed in New York, the suit accused Kiani of conspiring with RTW to temporarily boost the firm’s voting power to nearly 10% by purchasing shares shortly before key voting dates, then quickly reducing their stake afterward.
Masimo’s complaint also claims Kiani violated fair disclosure regulations by selectively sharing confidential company information with RTW, including key voting dates. Masimo contends Kiani—a personal investor in RTW-managed funds and close associate of RTW executives—regularly communicated with the investment firm through encrypted messages.
In a legal motion to dismiss Masimo’s lawsuit, Kiani claimed the company already investigated his alleged ties to RTW and came up empty. “Mr. Kiani does not currently, nor has he ever had, any agreement, arrangement, understanding, relationship, or otherwise with RTW or any of its affiliates…” the motion states.
Kiani also claims Masimo cannot prove its “empty voting” allegations, arguing in his complaint, “…the…allegations are insufficient to suggest that Mr. Kiani and TRW entered into any agreement to acquire, hold, vote, or dispose of Masimo securities. Instead, the well-pleaded factual allegations depict routine communications between Mr. Kiani and a significant shareholder regarding an important upcoming vote…”
Kiani further fired back at Masimo earlier this year by filing a notice against Masimo’s six Politan-affiliated board of directors for more than $100 million in statutory penalties. The Private Attorneys General Act notice to the California Labor & Workforce Development Agency allege the directors failed to award him a $400 million severance payout.
As he awaited his latest notice to work its way through the courts, Masimo decided in early August to drop its “empty voting” conspiracy claim against Kiani.
“This lawsuit was filed by Politan-controlled Masimo as an effort to avoid paying Mr. Kiani what he is owed under his 10-year-old employment agreement,” Hueston Hennigan partner John Hueston said. “The claim of an ‘empty voting’ conspiracy between Kiani and RTW was meritless. But now, to avoid a neutral judge’s scrutiny, Politan-controlled Masimo chose to dismiss the claim rather than face another contested loss.”
Maybe not a total loss: A federal judge in California upheld the lawsuit, ruling the company provided sufficient evidence that Kiani and RTW colluded to sway a board election.
Perhaps there’s another lesson to be learned.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !